Navigation Links
avVaa World Health Care Products Inc. Announces Access via Social Media Websites
Date:10/16/2009

LUMBY, BC, Oct. 16 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products, announced that they have launched pages on Blogger, Facebook and Twitter.

Recognizing investors' demand for non-traditional access to information, avVaa World Health Care Products Inc. has recently launched the weblog 'Executive's Desk' at www.avVaaExec.com. The blog will feature weekly posts from avVaa's top executive team including CEO Jack Farley, COO Lorie Campbell-Farley, and Controller Ruth Brennan. Posts will cover a range of topics, and include product reviews, business commentary, customer testimonials, and news announcements.

avVaa Investors and Neuroskin customers will also be able to follow avVaa on Facebook by searching 'avVaa World Health Care Products'. Facebook is one of the fastest growing social media sites online, whose American audience grew to 88 million unique viewers in September 2009.

avVaa will also regularly tweet updates on their Twitter site avVaaWorld. Twitter received over 23 million unique visitors in September.

"Our customers and investors want more information," commented Jack Farley. "With our social media sites, information is just the beginning. We can provide community and real-time interaction."

About avVaa World Health Care Products

avVaa World Health Care Products is a global biotechnology company that specializes in effective, all natural, therapeutic skin care products that improve quality of life and well being for consumers. avVaa's patented European skin care formulas are scientifically registered, FDA-Compliant, and were developed to relieve and treat the symptoms of common skin ailments, including eczema, psoriasis and acne. avVaa is poised to manufacture and market its OTC Neuroskin(R)) line of skin care products through mass, food and drug channels in the United States and globally. The Company's secondary line of equine and pet care related products are already being distributed throughout all of Canada. For more information, visit: www.avvaa.com.

Safe Harbor: Statements contained in this press release that are not based upon current or historical fact are forward looking in nature. Such forward-looking statements are subject to risks and uncertainties, which could cause actual results to differ materially from estimated results. Management cautions that all statements as to future results of operations are necessarily subject to risks, uncertainties, and events that may be beyond the control of avVaa World Health Care Products, Inc. and no assurance can be given that such results will be achieved.

Potential risks and uncertainties include but are not limited to the ability to procure, properly price, retain, and successfully complete projects, the availability of technical personnel, changes in technology, and competition.

CONTACT: Inquiries: info@avvaa.com; Public Relations: Merle Goertz (West Coast), (604) 688-2349

SOURCE avVaa World Health Care Products


'/>"/>
SOURCE avVaa World Health Care Products
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. avVaa World Health Care Products Inc. Announces DRTV Test Television Stations
2. avVaa World Health Care Products Inc. Announces Second DRTV Test Week
3. avVaa World Health Care Products, Inc. Announces the completion of its first week of DRTV 120/60 second test commercials for Neuroskin(R) Psoriasis Relief
4. avVaa World Health Care Products Inc. Announces Web Site Design for Neuroskin(R) Psoriasis Relief DRTV Campaign
5. avVaa World Health Care Products, Inc. Signs Agreement with 3PL Worldwide, Inc., for Order Management & Fulfillment for avVaas Product
6. avVaa World Health Care Products, Inc. Announces Engagement of Koeppel Direct for their DRTV-Direct Response Television Media Buying Campaign
7. Cepheid Expands Leadership Team With Appointment of Executive Vice President of Worldwide Commercial Operations
8. The 2010 Bio-IT World Best Practices Call for Entries has been Released -- Highlight your Company's Excellence in Innovation
9. Healthnostics Medbioworld.com Portal Web Site to Include Social Networking Features
10. Novavax CEO to Present at the World Vaccine Congress 2009, Lyon, France
11. Healthnostics Unveils Biomedical Content Strategy for Medbioworld.com
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)...  Imanis Life Sciences announced today the launch ... viruses for virotherapy research. These viruses are licensed ... vaccinia virus-based technology platform for research use. ... partnership with Genelux to offer researchers, for the ... in research," said Dr. Kah Whye Peng ...
(Date:2/23/2017)... , ... February 23, 2017 , ... The Greater ... a new partnership with Compass Research . GGI's mission is to advance global ... to a child in need in honor of each clinical trial volunteer. The vision ...
(Date:2/22/2017)... -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused ... for companion animals, will host a live conference call on ... financial results from the fourth quarter and full year ended ... may access the audio webcast or use the ... ...
(Date:2/22/2017)... (PRWEB) , ... February 22, ... ... Collaborative (TOPEC), the leading medical education provider of women’s health, primary ... by the Accreditation Council for Continuing Medical Education (ACCME). ACCME’s Accreditation with ...
Breaking Biology Technology:
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:2/2/2017)... , Feb. 1, 2017  Central to ... and meaningful advances worldwide, The Japan Prize Foundation ... Prize, who have pushed the envelope in their ... and Communication. Three scientists are being recognized with ... achievements that not only contribute to the advancement ...
Breaking Biology News(10 mins):